Ultrasonographic and Laboratory Markers of Metabolic and Cardiovascular Disease Risk in Obese Women with Polycystic Ovary Syndrome

    February 2012
    Lucimara Facio Nobre Zueff, Wellington P. Martins, Carolina Sales Vieira, Rui Alberto Ferriani
    Image of study
    TLDR Obese women with PCOS are more likely to have fatty liver disease.
    The study investigated the relationship between polycystic ovary syndrome (PCOS) and markers of metabolic and cardiovascular disease risk in 90 obese women, with 45 diagnosed with PCOS and 45 serving as age-matched controls. The results indicated that women with PCOS had a significantly higher prevalence of non-alcoholic fatty liver disease (NAFLD) (73.3% vs. 46.7%, P < 0.01) and a higher free androgen index (FAI) (10.4% vs. 6.8%, P < 0.01). Additionally, there was a trend towards higher insulin levels and lower insulin sensitivity (as measured by QUICKI) and reduced flow-mediated dilation (FMD) of the brachial artery in the PCOS group, although these were not statistically significant. The study concluded that NAFLD is more common in obese women with PCOS, which is an important consideration for their healthcare, including the choice of contraceptives.
    Discuss this study in the Community →

    Cited in this study

    6 / 6 results